Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
12.36
-0.09 (-0.72%)
At close: Jul 19, 2024, 4:00 PM
12.35
-0.01 (-0.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Pliant Therapeutics Revenue

Pliant Therapeutics had revenue of $248.00K in the twelve months ending March 31, 2024. In the year 2023, Pliant Therapeutics had annual revenue of $1.58M.

Revenue (ttm)
$248.00K
Revenue Growth
-97.46%
P/S Ratio
3,006.56
Revenue / Employee
$1,570
Employees
158
Market Cap
745.63M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.58M-8.11M-83.69%
Dec 31, 20229.69M2.11M27.91%
Dec 31, 20217.57M-34.25M-81.89%
Dec 31, 202041.82M-15.24M-26.70%
Dec 31, 201957.05M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.13B
Phibro Animal Health 999.56M
Evolus 219.70M
Travere Therapeutics 183.23M
Sage Therapeutics 91.06M
4D Molecular Therapeutics 20.45M
Revenue Rankings